ClinicalTrials.govpublic full text
Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care
ischemic stroke, sp-8203 (otaplimastat), rtpa (recombinant tissue plasminogen activator), thrombolytic therapy, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873495
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.